็™ป้Œฒใ—ใฆๆ‹›ๅพ…ใƒชใƒณใ‚ฏใ‚’ๅ…ฑๆœ‰ใ™ใ‚‹ใจใ€ๅ‹•็”ปๅ†็”Ÿๅ ฑ้…ฌใจ็ดนไป‹ๅ ฑ้…ฌใ‚’็ฒๅพ—ใงใใพใ™ใ€‚

Hardik Shah
@AIStockSavvy
Software Developer | AI-Powered News Insights, Earnings Reports and Analyst Ratings | Follow for Savvy Insights, Not Advice #AI# #StockMarket#
ๅ‚ๅŠ  September 2009
1.2K ใƒ•ใ‚ฉใƒญใƒผไธญ    41.1K ใƒ•ใ‚กใƒณ
$MRNA | Bernstein SocGen Group ๐—ฟ๐—ฒ๐—ถ๐˜๐—ฒ๐—ฟ๐—ฎ๐˜๐—ฒ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฃ๐—ฒ๐—ฟ๐—ณ๐—ผ๐—ฟ๐—บ on ๐— ๐—ผ๐—ฑ๐—ฒ๐—ฟ๐—ป๐—ฎ, maintains PT at $๐Ÿฐ๐Ÿฑ Analyst sees Intismeran as the clearest mRNA platform validation, with expansion now the key question.
ใ‚‚ใฃใจ่ฆ‹ใ‚‹